chr17-49133190-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000300404.2(B4GALNT2):āc.165T>Gā(p.Phe55Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 1,507,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000300404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
B4GALNT2 | NM_001159387.2 | c.14+384T>G | intron_variant | ENST00000393354.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
B4GALNT2 | ENST00000300404.2 | c.165T>G | p.Phe55Leu | missense_variant | 1/11 | 1 | |||
B4GALNT2 | ENST00000393354.7 | c.14+384T>G | intron_variant | 1 | NM_001159387.2 | P1 | |||
B4GALNT2 | ENST00000504681.5 | c.-65+680T>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 151954Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000906 AC: 1AN: 110378Hom.: 0 AF XY: 0.0000162 AC XY: 1AN XY: 61780
GnomAD4 exome AF: 0.00000738 AC: 10AN: 1355674Hom.: 0 Cov.: 34 AF XY: 0.00000896 AC XY: 6AN XY: 669812
GnomAD4 genome AF: 0.000112 AC: 17AN: 152072Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.165T>G (p.F55L) alteration is located in exon 1 (coding exon 1) of the B4GALNT2 gene. This alteration results from a T to G substitution at nucleotide position 165, causing the phenylalanine (F) at amino acid position 55 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at